Navigation Links
Botox Offers Little Relief for Migraine, Study Finds
Date:4/25/2012

By Serena Gordon
HealthDay Reporter

TUESDAY, April 24 (HealthDay News) -- Botox is considered a preventive medication for debilitating migraine headaches, but a new review finds that it may only help people with chronic migraines or chronic daily headaches. And, even then, the effect appears to only be "small to modest."

The review found that Botox (botulinum toxin A) was no help for people with episodic migraines (fewer than 15 a month) or chronic tension-type headaches.

"Our analyses suggest that botulinum toxin A may be associated with improvement in the frequency of chronic migraine and chronic daily headaches, but not with improvement in the frequency of episodic migraine, chronic tension-type headaches or episodic tension-type headaches. However, the association of botulinum toxin A with clinical benefit was small," wrote the authors of the review.

Still, the review's lead author, Dr. Jeffrey Jackson, said, "If I was having more than 15 migraines a month, I'd give Botox a try. It has few side effects. And, if it helps, you can go 90 days without as many headaches and without daily side effects." Jackson is a professor of medicine at the Medical College of Wisconsin in Milwaukee.

Results of the review are published in the April 25 issue of the Journal of the American Medical Association.

More than 40 percent of adults experience tension-type headaches at some point in their lives, according to background information in the article. Between 8 and 18 percent of adults have had migraines.

Treatment for these serious headaches fall into two general classes: abortive or preventive. The abortive medications are faster-acting, and can help stop a migraine or its symptoms while it's occurring. Preventive medications are taken to stop the headaches from occurring in the first place.

Botox's effect on migraines was discovered coincidentally when people who were having Botox injections to lessen lines and wrinkles in their foreheads noticed that their headaches were improved.

The current review examined 31 clinical trials. Twenty-seven were comparisons of Botox to placebo, including 5,313 patients. The remaining four studies were randomized clinical trials comparing Botox to medications commonly used to treat serious headaches. The drugs included amitriptyline (Elavil), prednisone, topiramate (Topamax) and valproate (Depakote).

When the researchers looked at the placebo-controlled trials, they found that Botox was associated with about two fewer headaches a month for people with chronic migraines and those with chronic daily headache. There was no statistically significant difference in people with episodic migraines or chronic tension-type headaches who were treated with Botox vs. placebo.

Botox wasn't associated with a reduction in the frequency of chronic migraines compared to topiramate or amitriptyline, or in the reduction of frequency of chronic or episodic migraines compared to valproate, according to the review. Botox did reduce headache severity more than methylprednisone, according to one study included in the review.

Side effects from Botox included a drooping eyelid, muscle weakness, neck pain, neck stiffness, skin tightness and a tingling, burning or numb sensation on the skin.

"If done properly, there really aren't substantial (side) effects from the use of Botox," explained Dr. Ezriel Kornel, a neurosurgeon at Northern Westchester Hospital in Mt. Kisco, N.Y. "But, over time the effect may wear off. Some people can develop an immunity to Botox."

Both Jackson and Kornel noted that there was a large placebo effect seen in many of the studies. "It's hard to know if most of the benefit was from the drug or from the placebo effect," said Jackson, who added, "but, patients don't care if it's a placebo effect."

Kornel said that the review showed that there is definitely some benefit from Botox for those with chronic migraine and chronic daily headache. "Chronic migraines are the hardest headaches to treat, and this gives us one more treatment in our armamentarium. It's a reasonable alternative to the use of long-term daily medications that can have side effects," Kornel said.

He said there are also other treatments that can help these types of headaches, and what's most important for someone who has debilitating headaches is to see a doctor who specializes in treating headaches. "A headache specialist has the whole array of treatments at their disposal," he said.

More information

Learn more about migraine headaches and their treatment from the National Headache Foundation.

SOURCES: Jeffrey Jackson, M.D., M.P.H., professor of medicine, Medical College of Wisconsin, Milwaukee; Ezriel Kornel, M.D., neurosurgeon, and director, Institute for Neurosciences, Northern Westchester Hospital, Mt. Kisco, N.Y.; April 25, 2012, Journal of the American Medical Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Anti-Wrinkle Gel Might Work Like Botox Without Needles
2. Study Finds Botox Alternative Better at Smoothing Crows Feet
3. Freezing Wrinkles a Possible Alternative to Botox
4. Botox May Temporarily Paralyze Emotions, Too
5. Botox reduces wrinkles even in less frequent doses
6. Botox Injections May Relieve Tennis Elbow Pain
7. BOTOX Cosmetic & Wrinkle Filler Specialist Hosts Advanced Training Event at Ageless Beauty in Mountain Home, ID
8. Botox May Prevent Some Migraines
9. New Book Reveals How Qigong Could Be The Eastern Answer To Botox
10. Wilderness Medicine founder offers health tips for summer season
11. Mayo Clinic offers newly approved treatment for acid reflux disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Botox Offers Little Relief for Migraine, Study Finds
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: